Literature DB >> 9882323

Radiation-resistant and radiation-sensitive forms of host resistance to polyomavirus.

J P Carroll1, J S Fung, R T Bronson, E Razvi, T L Benjamin.   

Abstract

Newborn mice of several inbred strains develop few or no tumors following inoculation with highly tumorigenic strains of polyomavirus. Here we show that such resistant strains can be divided into two groups based on the responses of adult mice to radiation followed by virus inoculation. Most strains show a radiation-sensitive form of resistance (Rr-s) and develop tumors following radiation and virus challenge. This type of resistance has previously been recognized as immunological, based on T-cell responses against virus-encoded neoantigen(s) expressed in tumor cells. Other strains exhibit a radiation-resistant form of resistance (Rr-r) and fail to develop tumors when treated in the same manner. Three additional properties of Rr-r mice distinguish them from Rr-s mice: (i) survival of newborns following inoculation with a highly virulent and usually lethal strain of virus, (ii) resistance to virus spread in newborns inoculated with either tumorigenic or virulent virus strains, and (iii) dominant or semidominant transmission of resistance in crosses with a highly susceptible strain. The Rr-r phenotype reflects a constitutive nonimmunological type of resistance that is targeted to the virus and blocks its dissemination.

Entities:  

Mesh:

Year:  1999        PMID: 9882323      PMCID: PMC103942     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  THE ROLE OF THYMUS IN TRANSPLANTATION RESISTANCE INDUCED BY POLYOMA VIRUS.

Authors:  R C TING; L W LAW
Journal:  J Natl Cancer Inst       Date:  1965-04       Impact factor: 13.506

2.  Influence of total body x-irradiation on tumor induction by parotid tumor agent in adult mice.

Authors:  L W LAW; C J DAWE
Journal:  Proc Soc Exp Biol Med       Date:  1960-11

3.  Effects of antilymphocyte serum on virus oncogenesis.

Authors:  A C Allison; L W Law
Journal:  Proc Soc Exp Biol Med       Date:  1968-01

4.  Immunologic responsiveness and the induction of experimental neoplasms.

Authors:  L W Law
Journal:  Cancer Res       Date:  1966-06       Impact factor: 12.701

5.  Genetic and structural analysis of a virulence determinant in polyomavirus VP1.

Authors:  P H Bauer; R T Bronson; S C Fung; R Freund; T Stehle; S C Harrison; T L Benjamin
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

6.  A determinant of polyomavirus virulence enhances virus growth in cells of renal origin.

Authors:  J B Bolen; S E Fisher; K Chowdhury; T C Shan; J E Williams; C J Dawe; M A Israel
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

7.  Duplication of noncoding sequences in polyomavirus specifically augments the development of thymic tumors in mice.

Authors:  R Freund; C J Dawe; T L Benjamin
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

8.  Structure of murine polyomavirus complexed with an oligosaccharide receptor fragment.

Authors:  T Stehle; Y Yan; T L Benjamin; S C Harrison
Journal:  Nature       Date:  1994-05-12       Impact factor: 49.962

9.  Pyvs: a dominantly acting gene in C3H/BiDa mice conferring susceptibility to tumor induction by polyoma virus.

Authors:  A E Lukacher; R Freund; J P Carroll; R T Bronson; T L Benjamin
Journal:  Virology       Date:  1993-09       Impact factor: 3.616

10.  Variations in polyoma virus genotype in relation to tumor induction in mice. Characterization of wild type strains with widely differing tumor profiles.

Authors:  C J Dawe; R Freund; G Mandel; K Ballmer-Hofer; D A Talmage; T L Benjamin
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

View more
  11 in total

Review 1.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

2.  Discrimination between sialic acid-containing receptors and pseudoreceptors regulates polyomavirus spread in the mouse.

Authors:  P H Bauer; C Cui; W R Liu; T Stehle; S C Harrison; J A DeCaprio; T L Benjamin
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

3.  Wild-derived inbred mice have a novel basis of susceptibility to polyomavirus-induced tumors.

Authors:  P Velupillai; I Yoshizawa; D C Dey; S R Nahill; J P Carroll; R T Bronson; T L Benjamin
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

4.  Expression of major capsid protein VP-1 in the absence of viral particles in thymomas induced by murine polyomavirus.

Authors:  N Sanjuan; A Porrás; J Otero; S Perazzo
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

5.  Polymorphisms in toll-like receptor 4 underlie susceptibility to tumor induction by the mouse polyomavirus.

Authors:  Palanivel Velupillai; Chang Kyoo Sung; Erik Andrews; Jennifer Moran; David Beier; Jonathan Kagan; Thomas Benjamin
Journal:  J Virol       Date:  2012-08-15       Impact factor: 5.103

6.  Systemic polyomavirus genome increase and dissemination of capsid-defective genomes in mammary gland tumor-bearing mice.

Authors:  J J Wirth; L Chen; M M Fluck
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

7.  Susceptibility to polyomavirus-induced tumors in inbred mice: role of innate immune responses.

Authors:  Palanivel Velupillai; John P Carroll; Thomas L Benjamin
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

8.  Inflammatory cytokine-mediated evasion of virus-induced tumors from NK cell control.

Authors:  Rabinarayan Mishra; Bojan Polic; Raymond M Welsh; Eva Szomolanyi-Tsuda
Journal:  J Immunol       Date:  2013-06-14       Impact factor: 5.422

Review 9.  Pathogen-host standoff: immunity to polyomavirus infection and neoplasia.

Authors:  Aron E Lukacher
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 10.  Immunity to polyomavirus infection: the polyomavirus-mouse model.

Authors:  Phillip A Swanson; Aron E Lukacher; Eva Szomolanyi-Tsuda
Journal:  Semin Cancer Biol       Date:  2009-02-14       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.